Selentium Group AG Launches HippocrAI Lite: A Free AI Health Assistant Accessible via Telegram
Swiss-based Selentium Group AG has introduced HippocrAI Lite, a consumer-focused AI health assistant available free of charge through the Telegram messaging platform. This new offering extends the advanced medical AI capabilities of Selentium’s flagship HippocrAI system—currently deployed in healthcare facilities—to individual users, providing accessible, anytime health support.
Democratizing Healthcare Through AI
HippocrAI Lite embodies Selentium’s commitment to making high-level medical intelligence widely available. It is designed to help users better understand their health status by interpreting medical tests and symptoms, forecasting potential health risks, and guiding them toward appropriate medical care. The platform is intended as a digital companion that encourages early, informed health decisions rather than a substitute for professional medical consultation.
Core Functionalities of HippocrAI Lite
- Diagnostics and Analysis: The AI reads laboratory results and medical documents, interprets imaging such as MRI, CT, X-rays, and ultrasounds, and identifies anomalies or risk factors.
- Predictive Medicine: It forecasts disease progression over 6 to 12 months, calculates probabilities of complications in real time, and issues early warnings based on test results or symptoms.
- Recommendations and Lifestyle Guidance: The assistant provides advice on nutrition, prevention, specialist consultations, and medication risk assessments.
Leadership Perspectives
Marsel Murtazin, CEO of Selentium Group AG, emphasized the platform’s mission: “HippocrAI is already redefining professional medicine for doctors and clinics. With HippocrAI Lite, we are taking the same intelligence and giving it directly to people—free, instant, and available through the most common platform, Telegram. Healthcare should not be a privilege. It should be a right, supported by the best AI in the world.”
David Levinson, CTO of HippocrAI, highlighted the technological achievement: “Building HippocrAI Lite was not just about creating another chatbot—it was about compressing the intelligence of a hospital into the palm of a hand. We engineered the system to read lab results, interpret scans, and forecast risks in seconds, using the same AI backbone trusted by medical professionals. What was once available only to clinics is now free for every citizen. This is the future of preventive healthcare.”
About HippocrAI and Selentium Group AG
HippocrAI is Selentium Group AG’s flagship AI platform that supports medical professionals by integrating electronic health records, lab data, imaging, and clinical histories to enhance diagnostic accuracy and predictive risk modeling. HippocrAI Lite distills this expertise into a simplified, user-friendly format for everyday health management.
Selentium Group AG is a Swiss holding company that consolidates several AI ventures across finance, healthcare, mobility, media, and urban development. Its mission is to revolutionize key industries through applied artificial intelligence.
Users can access HippocrAI Lite on Telegram at https://t.me/HippocrLite_bot.
FinOracleAI — Market View
The launch of HippocrAI Lite is likely to have a positive short-term impact by expanding the user base of AI-driven health tools beyond clinical settings to everyday consumers. This democratization of medical AI can drive wider adoption and increase brand recognition for Selentium Group AG. However, risks include regulatory scrutiny and user trust challenges since the platform does not replace professional medical advice. Market participants should monitor user engagement metrics, regulatory developments, and potential partnerships with healthcare providers to assess long-term viability.
Impact: positive
